On June 11, FDA announced the withdrawal of the Unified Agenda entry

FDA Withdraws Regulatory Notice Related to Premium Cigars from the Unified Agenda On June 11, FDA announced the withdrawal of the Unified Agenda entry pertaining to the advance notice of proposed rulemaking (ANPRM) for premium cigars issued in March 2018, as well as a related request for information (RFI). The agency has posted a web statement that includes background information on the ANPRM and RFI as well as FDA's rationale for this action. FDA expects to update the public in spring of 2022 following the completion of an ongoing review being conducted by the National Academies of Sciences, Engineering, and Medicine (NASEM) under contract with FDA. The study findings are expected to further inform the agency's regulatory policy.   Read Web Statement

Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA